| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 705-711, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
PJ van Diest, RJ Michalides, L Jannink, P van der Valk, HL Peterse, JS de Jong, CJ Meijer and JP Baak
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
Cyclin D1 overexpression, detected by standard immunohistochemistry, was correlated with other prognostic variables and its prognostic value was evaluated in a group of 148 invasive breast cancers with long-term follow-up. Overexpression of cyclin D1 (59% of cases) was negatively correlated (chi 2 test) with histological grade (P = 0.0001), mean nuclear area (P = 0.004), mean nuclear volume (P = 0.02), and mitotic activity (P = 0.03) and positively correlated with estrogen receptor (P = 0.0001). There was a strong correlation between cyclin D1 overexpression and histological type (P = 0.0001). Positive cyclin D1 staining was seen in 11 of 13 tubular carcinomas, 3 of 3 mucinous carcinomas, 4 of 4 invasive cribriform carcinomas, and 17 of 20 lobular carcinomas. Of 102 ductal cancers, 52 were positive, and all 6 medullary carcinomas were negative. There were no significant correlations with lymph node status, tumor size, or DNA ploidy. In survival analysis, cyclin D1 overexpression did not provide significant univariate or multivariate prognostic value. In conclusion, cyclin D1 is mainly overexpressed in the well differentiated and lobular types of invasive breast cancer and is strongly associated with estrogen receptor positivity. It is negatively correlated with the proliferation marker mitoses count and with the differentiation markers nuclear area and nuclear volume. However, cyclin D1 overexpression does not seem to have prognostic value in invasive breast cancer when no adjuvant treatment is given.
This article has been cited by other articles:
 |
|
 |
|
  S. Trent, C. Yang, C. Li, M. Lynch, and E. V. Schmidt Heat Shock Protein B8, a Cyclin-Dependent Kinase Independent Cyclin D1 Target Gene, Contributes to Its Effects on Radiation Sensitivity Cancer Res., November 15, 2007; 67(22): 10774 - 10781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lee, W. C. Park, H. W. Yim, M. A. Lee, G. Park, and K. Y. Lee Expression of c-erbB2, cyclin D1 and Estrogen Receptor and their Clinical Implications in the Invasive Ductal Carcinoma of the Breast Jpn. J. Clin. Oncol., September 1, 2007; 37(9): 708 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yang, S. Trent, V. Ionescu-Tiba, L. Lan, T. Shioda, D. Sgroi, and E. V. Schmidt Identification of Cyclin D1- and Estrogen-Regulated Genes Contributing to Breast Carcinogenesis and Progression Cancer Res., December 15, 2006; 66(24): 11649 - 11658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Li, F. Sotgia, M. A. Vuolo, M. Li, W. C. Yang, R. G. Pestell, J. A. Sparano, and M. P. Lisanti Caveolin-1 Mutations in Human Breast Cancer: Functional Association with Estrogen Receptor {alpha}-Positive Status Am. J. Pathol., June 1, 2006; 168(6): 1998 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know? Endocr. Rev., December 1, 2005; 26(7): 898 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Colozza, E. Azambuja, F. Cardoso, C. Sotiriou, D. Larsimont, and M. J. Piccart Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann. Onc., November 1, 2005; 16(11): 1723 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P J van Diest, E van der Wall, and J P A Baak Prognostic value of proliferation in invasive breast cancer: a review J. Clin. Pathol., July 1, 2004; 57(7): 675 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Reed, B. Sandstad, R. Holm, and J. M. Nesland The Prognostic Impact of Hormone Receptors and c-erbB-2 in Pregnancy-Associated Breast Cancer and Their Correlation with BRCAI and Cell Cycle Modulators International Journal of Surgical Pathology, April 1, 2003; 11(2): 65 - 74. [Abstract] [PDF]
|
|
|
|
|
|
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Schroeder, J. Symowicz, and L. A. Schuler PRL Modulates Cell Cycle Regulators in Mammary Tumor Epithelial Cells Mol. Endocrinol., January 1, 2002; 16(1): 45 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Musgrove, L.-J. K. Hunter, C. S. L. Lee, A. Swarbrick, R. Hui, and R. L. Sutherland Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27Kip1 Association with Cyclin E-Cdk2 J. Biol. Chem., December 7, 2001; 276(50): 47675 - 47683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pervin, R. Singh, and G. Chaudhuri Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): Potential role of cyclin D1 PNAS, March 13, 2001; 98(6): 3583 - 3588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Stringer, A. G. Cooper, and S. B. Shepard Overexpression of the G-Protein Inwardly Rectifying Potassium Channel 1 (GIRK1) in Primary Breast Carcinomas Correlates with Axillary Lymph Node Metastasis Cancer Res., January 1, 2001; 61(2): 582 - 588. [Abstract] [Full Text]
|
|
|
|
 |
|
 A.-M. Hui, X. Li, Y.-Z. Shi, T. Takayama, G. Torzilli, and M. Makuuchi Cyclin D1 Overexpression Is a Critical Event in Gallbladder Carcinogenesis and Independently Predicts Decreased Survival for Patients with Gallbladder Carcinoma Clin. Cancer Res., November 1, 2000; 6(11): 4272 - 4277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Flørenes, R. S. Faye, G. M. Mælandsmo, J. M. Nesland, and R. Holm Levels of Cyclin D1 and D3 in Malignant Melanoma: Deregulated Cyclin D3 Expression Is Associated with Poor Clinical Outcome in Superficial Melanoma Clin. Cancer Res., September 1, 2000; 6(9): 3614 - 3620. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Y. Zhang, S. C. Liu, L. F. Al-Saleem, D. Holloran, J. Babb, X. Guo, and A. J. P. Klein-Szanto E2F-1: A Proliferative Marker of Breast Neoplasia Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 395 - 401. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Takano, Y. Kato, P. J. van Diest, M. Masuda, H. Mitomi, and I. Okayasu Cyclin D2 Overexpression and Lack of p27 Correlate Positively and Cyclin E Inversely with a Poor Prognosis in Gastric Cancer Cases Am. J. Pathol., February 1, 2000; 156(2): 585 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Kenny, R. Hui, E. A. Musgrove, J. M.W. Gee, R. W. Blamey, R. I. Nicholson, R. L. Sutherland, and J. F. R. Robertson Overexpression of Cyclin D1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer Clin. Cancer Res., August 1, 1999; 5(8): 2069 - 2076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. DONNELLAN and R. CHETTY Cyclin E in human cancers FASEB J, May 1, 1999; 13(8): 773 - 780. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. M.L. Zwijsen, R. S. Buckle, E. M. Hijmans, C. J.M. Loomans, and R. Bernards Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1 Genes & Dev., November 15, 1998; 12(22): 3488 - 3498. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Dobashi, M. Shoji, S.-X. Jiang, M. Kobayashi, Y. Kawakubo, and T. Kameya Active Cyclin A-CDK2 Complex, a Possible Critical Factor for Cell Proliferation in Human Primary Lung Carcinomas Am. J. Pathol., September 1, 1998; 153(3): 963 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chu and D. S. Kohtz Identification of the E2A Gene Products as Regulatory Targets of the G1 Cyclin-dependent Kinases J. Biol. Chem., March 9, 2001; 276(11): 8524 - 8534. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
